Tag: COPD
ATS Issues Guideline on Home Oxygen Therapy for COPD, ILD
Long-term oxygen therapy strongly recommended for adults with COPD, ILD who have severe chronic resting hypoxemia
Cannabinoid Use Tied to Adverse Outcomes With COPD
In older adults with COPD, cannabinoid use tied to all-cause mortality, hospitalizations
HRRP Tied to Decrease in 30-Day Readmission Rates for COPD
But increase seen in 30-day risk-standardized postdischarge mortality rates for COPD patients
Perrigo Asthma Inhalers Recalled Due to Clog Risk
Some of the recalled albuterol sulfate inhalers stop working after several uses
ATS Issues Recommendations for Noninvasive Ventilation in COPD
Use of nocturnal NIV suggested as well as usual care for patients with chronic stable hypercapnic COPD
Health Expenditures Considerable for Asthma, COPD in U.S. Workers
Annualized total medical expenditures are $7 billion and $5 billion, respectively
Triple Inhaled Therapy Aids in Moderate-to-Very Severe COPD
Benefit seen for twice-daily triple inhaled therapy with glucocorticoid, glycopyrrolate, formoterol
Dysanapsis Measured on CT Associated With COPD in Seniors
Incidence of COPD was significantly higher in lowest versus highest quartile of airway-to-lung ratio
Guideline Details Pharmacologic Management of COPD
Clinical practice guideline addresses six emerging questions around COPD management
Pulmonary Rehab Associated With Lower COPD Mortality
Only 1.5 percent of patients initiated pulmonary rehabilitation within 90 days of discharge
